Professional Seasonal Analysis for Trading

Arrowhead Pharmaceuticals, Inc. - Common Stock (ARWR)

Seasonality Analysis

Stocks 27 Years Analyzed

Arrowhead Pharmaceuticals, Inc. - Common Stock Annual Seasonality Statistics

51.24%
Avg Annual Return
46.8%
Avg Monthly Win Rate
9/12
Positive Months
27
Years Analyzed

Arrowhead Pharmaceuticals, Inc. - Common Stock Monthly Seasonality Performance

Month Avg Return Win Rate Strength
January BEST 18.69%
52%
Moderate
February WORST -4.47%
41%
Weak
March 9.03%
52%
Moderate
April 10.21%
48%
Weak
May 0.83%
38%
Weak
June 1.80%
54%
Moderate
July 3.23%
50%
Weak
August 2.74%
38%
Weak
September -1.80%
46%
Weak
October -3.38%
46%
Weak
November 2.39%
50%
Weak
December 11.95%
46%
Weak

Arrowhead Pharmaceuticals, Inc. - Common Stock 2026 vs Historical Pattern

Current Position
76.79
Historical Avg Position
27.59
Deviation
+49.2
Performance
Significantly Above Average

Arrowhead Pharmaceuticals, Inc. - Common Stock Interactive Seasonality Chart

Interactive Seasonality Chart

Unlock the full interactive seasonality chart for ARWR with overlay patterns, custom date ranges, and more.

Create Free Account

Arrowhead Pharmaceuticals, Inc. - Common Stock Pattern Scanner

Pattern Scanner

Discover recurring patterns, anomalies, and statistically frequent setups.

Create Free Account

Arrowhead Pharmaceuticals, Inc. - Common Stock Seasonal Historical Performance

Historical Performance

See historical average returns for ARWR across multiple timeframes.

Create Free Account

About Arrowhead Pharmaceuticals, Inc. - Common Stock (ARWR) Seasonality

Arrowhead Pharmaceuticals, Inc. - Common Stock (ARWR) has been analyzed using 27 years of historical data to identify seasonal patterns. Classified under Stocks, Arrowhead Pharmaceuticals, Inc. - Common Stock shows distinct seasonal tendencies based on historical data.

The strongest month for Arrowhead Pharmaceuticals, Inc. - Common Stock is historically January, with an average return of 18.69% and a win rate of 52%. Conversely, February tends to be the weakest month, averaging -4.47% return.

Looking at the full calendar year, Arrowhead Pharmaceuticals, Inc. - Common Stock has an average annual return of 51.24% with an overall monthly win rate of 46.8%. Out of 12 months, 9 typically show positive average returns.

The seasonal pattern for Arrowhead Pharmaceuticals, Inc. - Common Stock has a consistency score of 39.7 (Poor), based on 27 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.

Arrowhead Pharmaceuticals, Inc. - Common Stock Seasonality FAQ

What is the best month to buy Arrowhead Pharmaceuticals, Inc. - Common Stock (ARWR)?

Historically, January has been the best month for Arrowhead Pharmaceuticals, Inc. - Common Stock, with an average return of 18.69% and a win rate of 52%. However, past performance does not guarantee future results.

What is the worst month for Arrowhead Pharmaceuticals, Inc. - Common Stock (ARWR)?

Based on historical data, February has been the weakest month for Arrowhead Pharmaceuticals, Inc. - Common Stock, with an average return of -4.47%. This is a historical observation and does not guarantee future results.

How reliable is ARWR seasonality data?

The seasonality analysis for Arrowhead Pharmaceuticals, Inc. - Common Stock is based on 27 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.

How can I use Arrowhead Pharmaceuticals, Inc. - Common Stock seasonality in my trading?

Use Arrowhead Pharmaceuticals, Inc. - Common Stock (ARWR) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.

More Stocks Seasonality Analysis

Statistical information based on historical data. Does not constitute investment advice or recommendation. Past performance does not guarantee future results.